{"id":"W2071306106","doi":"10.2310/7750.2006.00060a","title":"Biologic Therapeutics in the Treatment of Psoriasis. Part 1: Review","year":2007,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre; Dalhousie University","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Etanercept; Adalimumab; Infliximab; Dermatology; Biosimilar; Clinical trial; Immunology; Biologic Agents; Proinflammatory cytokine; Daclizumab; Plaque psoriasis; Tumor necrosis factor alpha; Monoclonal antibody; Inflammation; Pathology; Internal medicine; Antibody; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006112159,0.001399335,0.002104131,0.004242717,0.0003760672,0.001293695,0.0009451443,0.001395831,0.004965],"category_scores_gemma":[0.0009209886,0.0003777719,0.0007058632,0.004673322,0.0006599579,0.001751574,0.0005248562,0.00177168,0.003399118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007937386,"about_ca_system_score_gemma":0.001064654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001192162,"about_ca_topic_score_gemma":0.001782991,"domain_scores_codex":[0.9996118,0.00008624968,0.0000776797,0.00005120178,0.0001469697,0.00002616206],"domain_scores_gemma":[0.9994645,0.0002672828,0.0001033844,0.00001494704,0.0001052327,0.00004475114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001030232,0.0001484447,0.0002013573,0.04608682,0.0001531043,0.0004604885,0.0001101893,0.0003244918,0.00164046,0.001602792,0.0547163,0.8944525],"study_design_scores_gemma":[0.00007519598,0.0001821673,0.0013989,0.01506092,0.0002714575,0.00503953,0.0001077667,0.00009607327,0.0004293465,0.001671176,0.9756417,0.00002576735],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004864393,0.9990479,0.00004565536,0.0001014222,0.0002069222,0.000007836842,0.000008499431,0.000004273852,0.0005288366],"genre_scores_gemma":[0.000378966,0.9986921,0.0001483161,0.0001568022,0.0002907345,0.00001039609,0.00001907459,0.000001137739,0.0003024611],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004965,"threshold_uncertainty_score":0.01660961,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1510673634777764,"score_gpt":0.3572197791623919,"score_spread":0.2061524156846155,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}